16 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

VITA PM 7 (20 GRAM BOTTLES), VITA PM 7 (50 GRAM BOTTLES)

FDA 510(k)
FDA Class 2 ·Dental

Prodigy Pocket Blood Glucose Monitoring System

FDA UDI
Prodigy Diabetes Care, LLC·00384840503625·Prodigy Pocket Blood Glucose Monitoring System ...

Merit Medical®

FDA UDI
Merit Medical Systems, Inc.·00884450483862·

MODIFICATION TO ZEUS SCIENTIFIC, INC., TPO IGG ELISA TEST SYSTEM

FDA 510(k)
FDA Class 2 ·Immunology

ACCU-CHEK COMFORT CURVE TEST STRIP

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

ERBE

FDA Adverse Event
Malfunction ·LEONHARD LANG GMBH·Product code GEI·November 2, 2022

ULTIMA ACTIVATOR II REUSABLE DRIVE MECH.

FDA Adverse Event
Malfunction ·MAQUET CARDIOVASCULAR, LLC·Product code MWS·April 8, 2013

PARADIGM REAL-TIME INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC MINIMED·Product code OYC·September 1, 2014

PARADIGM REAL-TIME REVEL INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS MED-REL·Product code MDS·April 4, 2011

ERBE

FDA Adverse Event
Malfunction ·LEONHARD LANG GMBH·Product code GEI·March 8, 2023

ERBE

FDA Adverse Event
Malfunction ·LEONHARD LANG GMBH·Product code GEI·February 18, 2025

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

FDA Adverse Event
Malfunction ·ABBOTT VASCULAR-CARDIAC THERAPIES·Product code NIQ·November 5, 2010

ERBE

FDA Adverse Event
Injury ·LEONHARD LANG GMBH·Product code GEI·July 27, 2022

Instructions For Use document of the GPS Trackers.

FDA Enforcement
Class II ·Terminated·Blue Ortho·November 4, 2020

Belmont Rapid Infuser, a Fluid Management System, Model FMS2000.

FDA Enforcement
Class II ·Terminated·Belmont Instrument Corporation·October 24, 2012

CADD-Solis VIP ambulatory Infusion Pumps, Model 2120 (21-2120, 21-2125, and 21-2127) Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.

FDA Enforcement
Class I ·Ongoing·Smiths Medical ASD Inc.·August 14, 2024